The effect of modafinil on fatigue, cognitive functioning, and mood in primary brain tumor patients: A multicenter randomized controlled trial

Neuro-Oncology

Volumn 15, Issue 10, 2013, Pages 1420-1428

  Boele, Florien W ^a   Douw, Linda ^a   De Groot, Marjolein ^a   Van Thuijl, Hinke F ^a   Cleijne, Wilmy ^a   Heimans, Jan J ^a   Taphoorn, Martin J B ^b   Reijneveld, Jaap C ^a   Klein, Martin ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

brain tumor; cognitive functioning; fatigue; HRQOL; modafinil; mood

Indexed keywords

MODAFINIL; PLACEBO;

ARTICLE; BRAIN TUMOR; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHECKLIST; CHECKLIST INDIVIDUAL STRENGTH; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FATIGUE; FEMALE; HEALTH; HEALTH SURVEY; HUMAN; INFORMATION PROCESSING; MALE; MENTAL HEALTH; MOTIVATION; MULTICENTER STUDY; OUTCOME ASSESSMENT; OUTPATIENT DEPARTMENT; PRIMARY TUMOR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SHORT FORM 36; SOCIAL INTERACTION; WORKING MEMORY;

BRAIN TUMOR; COGNITIVE FUNCTIONING; FATIGUE; HRQOL; MODAFINIL; MOOD;

ADULT; AGED; AGED, 80 AND OVER; BENZHYDRYL COMPOUNDS; BRAIN NEOPLASMS; COGNITION DISORDERS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FATIGUE; FEMALE; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MENINGEAL NEOPLASMS; MIDDLE AGED; MOOD DISORDERS; NEOPLASM GRADING; PROGNOSIS; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; QUESTIONNAIRES; WAKEFULNESS-PROMOTING AGENTS;

EID: 84885016714     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/not102     Document Type: Article

References (56)

1. Taphoorn MJB, Klein M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol. 2004;3:159-168. (Pubitemid 38229950)
2. Weitzner MA. Psychosocial and neuropsychiatric aspects of patients with primary brain tumors. Cancer Invest. 1999;17: 285-291. (Pubitemid 29202939)
3. Powell C, Guerrero D, Sardell S, et al. Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumours: a prospective study. Radiother Oncol. 2011;100:131-136.
4. Faithful S, Brada M. Somnolence syndrome in adults following cranial irradiation for primary brain tumours. Clinical Oncol. 1998;10:250-254. (Pubitemid 28454546)
5. Struik K, Klein M, Heimans JJ, et al. Fatigue in low-grade glioma. J Neurooncol. 2008;92:73-78.
6. Mukand JA, Blackinton DD, Crincoli MG, Lee JJ, Santos BB. Incidence of neurologic deficits and rehabilitation of patients with brain tumors. Am J Phys Med Rehabil. 2001;80:346-350. (Pubitemid 32378119)
7. Rooney AG, Carson A, Grant R. Depression in cerebral glioma patients: a systematic review of observational studies. J Nat Cancer Inst. 2011;103:61-76.
8. Pelletier G, Verhoef MJ, Khatri N, Hagen N. Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues. J Neurooncol. 2002;57:41-49. (Pubitemid 34692613)
9. Shaw EG, Rosdhal R, D'Agostino RB, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol. 2006;24:1415-1420. (Pubitemid 46622007)
10. Ballon JS, Feifel D. A systematic review of modafinil: potential clinical uses and mechanisms of action. J Clin Psychiatry. 2006;67: 554-566. (Pubitemid 43764232)
11. Lin JS, Hou Y, Jouvet M. Potential brain neuronal targets for amphetamine-, methylphenidate- and modafinil-induced wakefulness, as evidenced by c-fos immunocytochemistry in the cat. Proc Natl Acad Sci U S A. 1996;93:14128-14133. (Pubitemid 26424257)
12. Hou RH, Freeman C, Langley RW, Szabadi E, Bradshaw CM. Does modafinil activate the locus coeruleus in man? Comparison of modafinil and clonidine on arousal and autonomic functions in human volunteers. Psychopharmacology. 2005;181:537-549.
13. Myrick H, Malcolm R, Taylor B, LaRowe S. Modafinil: preclinical, clinical, and post-marketing surveillance-A review of abuse liability issues. Ann Clin Psychiatry. 2004;16:101-109. (Pubitemid 39089110)
14. Minzenberg MJ, Carter CS. Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology. 2008;33: 1477-1502. (Pubitemid 351684703)
15. Lundorff LE, Jonsson BH, Sjogren P. Modafinil for attentional and psychomotor dysfunction in advanced cancer: a double-blind, randomised, cross-over trial. Palliat Med. 2009;23:731-738.
16. Wong YN, King SP, Simcoe D, et al. Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects. J Clin Pharmacol. 1999;39:281-288. (Pubitemid 29148551)
17. Harris JD. Fatigue in chronically ill patients. Curr Opin Support Palliat Care. 2008;2:180-186.
18. Besset A, Chetrit M, Carlander B, Billiard M. Use of modafinil in the treatment of narcolepsy: a long term follow-up study. Neurophysiol Clin. 1996;26:60-66. (Pubitemid 26162087)
19. Boivin DB, Montplaisir J, Petit D, Lambert C, Lubin S. Effects of modafinil on symptomatology of human narcolepsy. Clin Neuropharmacol. 1993;16:46-53. (Pubitemid 23028497)
20. Jones DEJ, Newton JL. An open study of modafinil for the treatment of daytime somnolence and fatigue in primary biliary cirrhosis. Aliment Pharmacol Ther. 2007;25:471-476. (Pubitemid 46184461)
21. Carter GT, Han JJ, Mayadev A, Weiss MD. Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1a: a case series. Am J Hosp Palliat Care. 2006;23:412-416.
22. Pachas WN. Modafinil for fatigue in fibromyalgia. J Clin Rheumatol. 2003;9:282-285.
23. Carter GT,Weiss MD, Lou JS, et al. Modafinil to treat fatigue in amyotrophic lateral sclerosis: an open label pilot study. Am J Hosp Palliat Care. 2005;22:55-59. (Pubitemid 40208765)
24. Rabkin JG, Gordon PH, McElhiney M, Rabkin R, Chew S, Mitsumoto H. Modafinil treatment of fatigue in patients with ALS: a placebo-controlled study. Muscle Nerve. 2009;39:297-303.
25. Rabkin JG, McElhineyMC,Rabkin R, McGrath PJ. Modafinil treatment for fatigue in HIV/AIDS: a randomized placebo-controlled study. J Clin Psychiatry. 2010;71:707-715.
26. Zifko UA, Rupp M, Schwarz S, Zipko HT, Maida EM. Modafinil in treatment of fatigue in multiple sclerosis: results of an open-label study. J Neurol. 2002;249:983-987. (Pubitemid 35002216)
27. Niepel G, Bibani RH, Vilisaar J, et al. Association of a deficit of arousal with fatigue in multiple sclerosis: effect of modafinil. Neuropharmacology. 2012;64:380-388.
28. Taneja I, Haman K, Shelton RC, Robertson D. A randomized, doubleblind, crossover trial of modafinil on mood. J Clin Psychopharmacol. 2007;27:76-79. (Pubitemid 46105770)
29. Price CS, Taylor FB.A retrospective chart reviewof the effects of modafinil on depression as monotherapy and as adjunctive therapy. Depress Anxiety. 2005;21:149-153. (Pubitemid 41170383)
30. Lundt L. Modafinil treatment in patients with seasonal affective disorder/ winter depression: an open-label pilot study. J Affect Disord. 2004;81:173-178. (Pubitemid 39070093)
31. Joos L, Docx L, Schmaal L, Sabbe BGC, Dom G. Modafinil bij psychiatrische aandoeningen: de veelbelovende status opnieuw bekeken [Modafinil in psychiatric conditions: the promising status revisited]. Tijdschrift voor Psychiatrie. 2010;52:763-773.
32. Beusterien KM, Rogers AE,Walsleben JA, et al. Health-related quality of life effects of modafinil for treatment of narcolepsy. Sleep. 1999;22:757-765. (Pubitemid 29445343)
33. McElhiney M, Rabkin J, Gorp van W, Rabkin R. Modafinil effects on cognitive function in HIV+ patients treated for fatigue: a placebo controlled study. J Clin Exp Neuropsychol. 2010;32:474-480.
34. Scoriels L, Jones PB, Sahakian BJ. Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain. Neuropharmacology. 2012;64:168-184.
35. HunterMD, GanesanV, Wilkinson ID, Spence SA. Impact on modafinil on prefrontal executive function in schizophrenia. Am J Psychiatry. 2006;163:2184-2186. (Pubitemid 46114242)
36. Gill M, Haerich P,Westcott K, Godenick KL, Tucker JA. Cognitive performance following modafinil versus placebo in sleep-deprived emergency physicians: a double-blind randomized crossover study. Acad Emerg Med. 2008;13:158-165. (Pubitemid 43155822)
37. Kuczenski R, Segal DS. Effects of methylphenidate on extracellular dopamine, serotonin and norepinephrine: comparison with amphetamine. J Neurochem. 1997;68:2032-2037. (Pubitemid 27176139)
38. BerridgeCW, Devilbiss DM. Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines and attention deficit hyperactivity disorder. Biol Psychiatry. 2011;69:e101-e111.
39. Gehring K, Patwardhan SY, Collins R, et al. A randomized trial on the efficacy of methylphenidate andmodafinil for improving cognitive functioning and symptoms in patients with a primary brain tumor. J Neurooncol. 2012;107:165-174.
40. Kaleita TA, Wellisch DK, Graham CA, et al. Pilot study of modafinil for treatment of neurobehavioral dysfunction and fatigue in adult patients with brain tumors [abstract]. J Clin Oncol. 2006;24:1503.
41. Vercoulen JHMM, Albert M, Bleijenberg G. De Checklist Individual Strength (CIS). Gedragstherapie. 1999;32:131-136.
42. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Measure. 1977;1:385.
43. Aaronson NK, Muller M, Cohen PD, et al. Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations. J Clin Epidemiol. 1998;51: 1055-1068. (Pubitemid 28527161)
44. Stewart AL, Ware JE. (eds). Measuring Functioning and Well-Being: The MedicalOutcome Study Approach. Durham: Duke University Press
45. Rey A. L'examen psychologique dans les cas d'encephalopathie traumatique. Arch Psychologie. 1941;28:21.
46. Elst van derW, Boxtel van MPJ, Breukelen van GJP, Jolles J. Assessment of information processing in working memory applied settings: the paper & pencil memory scanning test. Psych Med. 2007;37:1335-1344. (Pubitemid 47244863)
47. Stroop J. Studies of interference in serial verbal reactions. J Exper Psychol. 1935;18:643-662.
48. Elst van derW, Boxtel van MPJ, Breukelen van GJP, Jolles J. The Letter Digit Substitution Test: normative data for 1,858 healthy participants aged 24-81 from the Maastricht Aging Study (MAAS): influence of age, education, and sex. J Clin Exp Neuropsychol. 2006;28:998-1009. (Pubitemid 44034738)
49. Elst van der W, Boxtel van MPJ, Breukelen van GJP, Jolles J. The concept shifting test: adult normative data. Psychol Assess. 2006;18:424-432. (Pubitemid 44950886)
50. Luteijn F, Ploeg FAF. GIT: Groninger Intelligentie Test. Lisse: Swets & Zeitlinger; 1983.
51. Bosma H, van Boxtel MP, Ponds RW, et al. Pesticide exposure and risk of mild cognitive dysfunction. Lancet. 2000;356:912-913.
52. Finniss DG, Kaptchuk TJ, Miller F, Benedetti F. Placebo effects: biological, clinical and ethical advances. Lancet. 2010;375:686-695.
53. Barsky AJ, Saintfort R, Rogers MP, Borus JF. Nonspecific medication side effects and the nocebo phenomenon. JAMA. 2002;287:622-627. (Pubitemid 34252015)
54. Armstrong TS, GilbertMR. Practical strategies for management of fatigue and sleep disorders in people with brain tumors. Neuro Oncol. 2012;14:iv65-iv72.
55. GehringK, SitskoornMM,GundyCM,et al. Cognitive rehabilitation in patients with gliomas: a randomized, controlled trial. J Clin Oncol. 2009;27:3712-3722.
56. Faller H, Schuler M, Richard M, Heckl U, Weis J, Kü ffner R. Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: systematic review and meta-analysis. J Clin Oncol. 2013;31:782-793.